Publications

Setting up haploidentical hematopoietic cell transplantation in low- and middle-income countries: The Recommendations of the Francophone Society of Bone Marrow and Cellular Therapy (SFGM-TC)
Hamzy F, Chevallier P, Bruno B, Coiteux V, El Kababri M, Ibrahim A, Oudrhiri A, Yakoub-Agha I, Bekadja MA.Bull Cancer. 2024 Oct 18
Assessing acute toxicity profiles of HLA-identical hematopoietic stem cell transplantation in pediatric patients with sickle cell anemia: A comprehensive analysis on behalf of the SFGM-TC
Delafoy M, Dalle JH, Pondarre C, Andrieu GP, Fahd M, Yakouben K, Castelle M, Koehl B, Neven B, Grain A; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Am J Hematol. 2024 Sep 24
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)
Tournilhac O, Altmann B, Friedrichs B, Bouabdallah K, Leclerc M, Cartron G, Turlure P, Reimer P, Wagner-Drouet E, Sanhes L, Houot R, Roussel M, Kroschinsky F, Dreger P, Viardot A, de Leval L, Rosenwald A, Gaulard P, Wulf G, Villate A, Latiere C, Elmaagacli A, Glass B, Poeschel V, Damaj G, Sibon D, Durot E, Bilger K, Banos A, Haenel M, Dreyling M, Keller U, Tiab M, Drenou B, Cornillon J, Nguyen S, Robin M, Nickelsen M, Trümper L, Lenz G, Ziepert M, Schmitz N; French Lymphoma Study Association (LYSA); Société Francophone de greffe de moelle et Thérapie Cellulaire (SFGM-TC); German Lymphoma Alliance (GLA); French Lymphoma Study Association (LYSA), Société Francophone de greffe de moelle et Thérapie Cellulaire (SFGM-TC), German Lymphoma Alliance (GLA).J Clin Oncol. 2024 Sep 13
Prerequisite and organisation of health-care pathways for Cell and Gene therapies, using Mesenchymal Stromal Cells (MSC) or Chimeric Antigen Receptor (CAR) T cells, in patients with autoimmune systemic diseases
Castilla-Llorente C, Bonnin A, Lansiaux P, Tudesq JJ, Beuvon C, Fabreguettes JR, Pers YM, Pugnet G, Maria ATJ, Puyade M, Urbain F, Terriou L, Poindron V, Jachiet M, Cacciatore C, Lescoat A, Prata PH, Munia I, Madelaine I, Thieblemont C, Tarte K, Yakoub-Agha I, Magro L, Farge D, Marjanovic Z.Bull Cancer. 2024 Sep 5
Place of hematopoietic stem cell transplantation for very high risk acute myeloblastic leukemia and myelodysplastic syndromes (SFGM-TC)
Mediavilla C, D'Aveni M, Huynh A, Joris M, Masouridi-Levrat S, Nguyen S, Turlure P, Magro L, Guillaume T.Bull Cancer. 2024 Sep 5
Clinical and transversal competencies of advanced practice nurses (APNs) within a cellular therapy team (SFGM-TC)
Jezequel T, Ajazi Hub R, Bompoint C, Chauvel C, Colonnese E, Corbineau C, Desmedt C, Kicki C, Lomazzi S, Sirvent A, Evard S, Roux K, Magro L, Colledani F.Bull Cancer. 2024 Sep 5
Preventing relapse of acute leukemias and myelodysplastic syndromes in post-allograft transplantation: Prophylactic and preemptive strategies (SFGM-TC)
Coiteux V, Abellan I, Ahmad I, Boisnard A, Busquet C, Ceballos P, Coman T, Godin S, Hermet É, Marcais A, Mamez AC, Quessar A, Souchet L, Magro L, Simon N.Bull Cancer. 2024 Sep 5
Acquired severe aplastic anemia in emerging countries: Management from allogeneic hematopoietic cell transplantation indication until post-transplant follow-up SFGM-TC
Yafour N, Bekadja MA, El Bejjaj I, Cheikh JE, El Kababri M, Magro L, Hamzy F.Bull Cancer. 2024 Sep 2
Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium
Flore Sicre de Fontbrune, Florian Chevillon, Mony Fahd, Kristell Desseaux, Xavier Poiré, Edouard Forcade, Arthur Sterin, Bénédicte Neven, Virginie Gandemer, Sylvain Thepot, Alice Garnier, Bruno Lioure, Ambroise Marcais, Stephanie Nguyen-Quoc, Suzanne Tavitian, Laure Vincent, Jean Donadieu, Matthieu Resche Riggon, Sylvie Chevret, Marlene Pasquet, Regis Peffault de Latour.BJHaem. 2024 Aug 19
Alemtuzumab-based conditioning regimen before hematopoietic stem cell transplantation in patients with short telomere syndromes: a retrospective study of the SFGM-TC
Hussein-Agha R, Kannengiesser C, Lainey E, Marcais A, Srour M, Sterin A, Buchbinder N, Borie R, Plessier A, Socié G, Peffault de Latour R, Sicre de Fontbrune F.Bone Marrow Transplant. 2024 Jul 30
Pre-, per- and post-allogeneic haematopoietic stem cell transplant rehabilitation (Atelier SFGM-TC)
Pinelli V, Christophe L, Cheron N, Morin S, Gilis L, Heuze C, Clerc-Renaud D, Morotti L, Vilhet B, Bissardon S, Magro L. Bull Cancer. 2024 Jul 8
Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?
Le Calvez B, Jullien M, Dalle JH, Renard C, Jubert C, Sterin A, Paillard C, Huynh A, Guenounou S, Bruno B, Gandemer V, Buchbinder N, Simon P, Pochon C, Sirvent A, Plantaz D, Kanold J, Béné MC, Rialland F, Grain A; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC). Hemasphere. 2024 Jul 8
Preventive and therapeutic strategies for relapse after hematopoietic stem cell transplant for pediatric AML (SFGM-TC)
Renard C, Corbel A, Paillard C, Pochon C, Schneider P, Simon N, Buchbinder N, Fahd M, Yakoub-Agha I, Calvo C. Bull Cancer. 2024 Jun 25
Diet guidelines in adult and pediatric patient after allogeneic stem cell transplantation (SFGM-TC)
Farrugia C, Lhostette A, Brasseur M, Biot T, Calmes H, Dendoncker C, Dupret AS, Estheve S, Filiol S, Guidi V, Hadrot L, Perez M, Ravinet A, Tardieu L, Magro L, Alfandari S, Simon N, Guenounou S, Cornillon J. Bull Cancer. 2024 Jun 25
EMERGINCaRE, le dispositif d’horizon scanning dédié aux médicaments anticancéreux développé par l’Institut national du cancerEMERGINCaRE, the horizon scanning system for anticancer drugs of the French National Cancer Institute
Duperray M, Bertin C, Sagot L, Breton T, Ifrah N. Bull Cancer. 2024 Jun 24
Fertility preservation and hematopoietic stem cell transplantation (SFGM-TC)
Chevillon F, Rebotier M, Dhédin N, Bruno B, Cacciatore C, Charbonier A, Joseph L, Le Bourgeois A, Talouarn M, Magro L, Barraud Lange V. ull Cancer. 2024 Jun 24
PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
Kaphan E, Bettega F, Vallet N, Fegueux N, Robin M, Bazarbachi A, Nguyen S, Beauvais D, Forcade E, De Oca MCM, Devillier R, Chevallier P, Loschi M, Huynh A, Bay JO, Rubio MT, Suarez F, Francois S, Poire X, Contentin N, Desmier D, Charbonnier A, Cornillon J, Chantepie S, Turlure P, Bulabois CE, Michonneau D, Villate A; SFGM-TC.Haematologica. 2024 Jun 13
Haematopoietic stem cell donation from minor donor: Respecting laws, assessing fitness, delivering information and good care (SFGM-TC)
Lejeune M, Menard B, Servais S, Andrianne C, Capelle L, De Maistre S, Fabaron C, Cornier MF, Goutagny MP, Pereira M, Tardy C, Turquet E, Benakli M, Baudoux E, Evard S, Faucher C, Herrero G; RESILIAM; Magro L, Geurten C. Bull Cancer. 2024 May 15
Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Alsuliman T, Aubrun C, Bay JO, Beguin Y, Bigenwald C, Brissot E, Chalandon Y, Chevallier P, Pagliuca S, Magro L, Srour M. Bull Cancer. 2024 Apr 16
Efficacy of eculizumab in transplantation-associated thrombotic microangiopathy: results of the French nationwide study on behalf of the SFGM-TC and the CNR-MAT
Peyre M, Sicre de Fontbrune F, Berceanu A, Benjemia L, Castelle M, D'Aveni M, Marçais A, Kaphan E, Bulabois CE, Sirvent A, Rohrlich PS, Coiteux V, Chantepie S, Nguyen-Quoc S, Peffault de Latour R, Coppo P. Bone Marrow Transplant. 2024 Apr 11
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
Villar S, Chevret S, Poire X, Joris M, Chevallier P, Bourhis JH, Forcade E, Chantepie S, Beauvais D, Raus N, Bay JO, Loschi M, Devillier R, Duléry R, Ceballos P, Rubio MT, Servais S, Nguyen S, Robin M. Bone Marrow Transplant. 2024 Mar 21
Update for cord blood unit selection in hematopoietic stem cell transplantation (workshop SFGM-TC)
Dubois V, Blandin L, Duclaut M, Duquesne A, Faivre L, Ferru-Clement R, Roy J, Walencik A, Magro L, Garnier F. Bull Cancer. 2024 Mar 13
Pediatric aphereses (workshop SFGM-TC)
Chabannon C, Benakli M, Alexandrova K, Coze C, Dalle JH, Giraud C, Huynh P, Kanouni T, Kanold J, Lesieur I, Levavasseur A, Yakoub-Agha I, Baudoux E. Bull Cancer. 2024 Mar 12
IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation
Caillet A, Simonet-Boissard M, Forcade E, Robin M, Rubio MT, Couturier MA, Srour M, Maillard N, Devillier R, Huynh A, Bourhis JH, Simand C, Chantepie S, Boisson C, Kroemer M, Deconinck E, Berceanu A. Hemasphere. 2024 Mar 10
Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC
Longval T, Leprêtre AC, Ravinet A, Fayard A, Forcade E, Coman T, Redjoul R, Berceanu A, Buchbinder N, Berlie G, Mappoura M, Giannotti F, Chevillon F, Robin M, Peffault de Latour R, Sicre de Fontbrune F; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplant. 2024 Mar 9
French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases
Farge D, Pugnet G, Allez M, Castilla-Llorente C, Chatelus E, Cintas P, Faucher-Barbey C, Labauge P, Labeyrie C, Lioure B, Maria A, Michonneau D, Puyade M, Talouarn M, Terriou L, Treton X, Wojtasik G, Zephir H, Marjanovic Z; MATHEC collaborators.Rev Med Interne. 2024 Feb
Relapse with HLA loss after hematopoietic stem cell transplantation with non-HLA identical donor: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)
Amokrane K, Cherel M, Rouzaire PO, Walencik A, Dubois V. Bull Cancer. 2024 Feb
On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients
Leroyer EH, Petitpain N, Morisset S, Neven B, Castelle M, Winter S, Souchet L, Morel V, Le Cann M, Fahd M, Yacouben K, Mechinaud F, Ouachée-Chardin M, Renard C, Wallet HL, Angoso M, Jubert C, Chevallier P, Léger A, Rialland F, Dhedin N, Robin C, Maury S, Beckerich F, Beauvais D, Cluzeau T, Loschi M, Fernster A, Bittencourt MC, Cravat M, Bilger K, Clément L, Decot V, Gauthier M, Legendre A, Larghero J, Ouedrani A, Martin-Blondel G, Pochon C, Reppel L, Rouard H, Nguyen-Quoc S, Dalle JH, D'Aveni M, Bensoussan D. Hemasphere. 2024 Jan 27
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry
Lacan C, Lambert J, Forcade E, Robin M, Chevallier P, Loron S, Bulabois CÉ, Orvain C, Ceballos P, Daguindau E, Charbonnier A, Chalandon Y, Bernard M, Simand C, Rubio MT, Turlure P, Maertens J, Huynh A, Loschi M, Bay JO, Guillerm G, Alani M, Castilla-Llorente C, Poiré X, Chantepie S, Maillard N, Beguin Y, Marçais A, Cornillon J, Malfuson JV, Maury S, Meuleman N, Villate A, Bekadja MA, Walter-Petrich A, Jacque N, Srour M, Devillier R, Nguyen S.J Hematol Oncol. 2024 Jan 7

Recherche

Publications

Recherche

Ressources médicales

SFGM-TC